Polyclonal Antibody to Plexin B1 (PLXNB1)    
    
PLXN5; SEP; Semaphorin receptor SEP
Overview
Properties
- Product No.PAH358Hu03
 - Organism SpeciesHomo sapiens (Human) Same name, Different species.
 - ApplicationsWB; IHC; ICC; IP.
If the antibody is used in flow cytometry, please check FCM antibodies.
Research use only - DownloadInstruction Manual
 - CategoryMetabolic pathway
 
- SourcePolyclonal antibody preparation, Host Rabbit
 - Ig Type IgG, Potency n/a
 - PurificationAntigen-specific affinity chromatography followed by Protein A affinity chromatography
 - LabelNone
 - Immunogen RPH358Hu03-Recombinant Plexin B1 (PLXNB1)
 - Buffer Formulation0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
 - TraitsLiquid, Concentration 500µg/mL
 
Sign into your account
Share a new citation as an author
Upload your experimental result
Review

Contact us
Please fill in the blank.
Specifity
The antibody is a rabbit polyclonal antibody raised against PLXNB1. It has been selected for its ability to recognize PLXNB1 in immunohistochemical staining and western blotting.
Usage
            Western blotting: 0.5-2µg/mL
Immunohistochemistry: 5-20µg/mL
Immunocytochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.        
Storage
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
Stability
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Organism Species More: Mus musculus (Mouse), Rattus norvegicus (Rat)Giveaways
Increment services
- 
                
                    Antibody Labeling Customized Service
                                 - 
                
                    Protein A/G Purification Column
                                 - 
                
                    Staining Solution for Cells and Tissue
                                 - 
                
                    Positive Control  for Antibody
                                 - 
                
                    Tissue/Sections Customized Service
                                 - 
                
                    Phosphorylated Antibody Customized Service
                                 - 
                
                    Western Blot (WB) Experiment Service
                                 - 
                
                    Immunohistochemistry (IHC) Experiment Service
                                 - 
                
                    Immunocytochemistry (ICC) Experiment Service
                                 - 
                
                    Flow Cytometry (FCM) Experiment Service
                                 - 
                
                    Immunoprecipitation (IP) Experiment Service
                                 - 
                
                    Immunofluorescence (IF) Experiment Service
                                 - 
                
                    Buffer
                                 - 
                
                    DAB Chromogen Kit
                                 - 
                
                    SABC Kit
                                 - 
                
                    Long-arm Biotin Labeling Kit
                                 - 
                
                    Real Time PCR Experimental Service
                                 
Citations
- Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatmentPubmed:25395071
 - A Revised Staging System for Waldenström's Macroglobulinemia10.1016/j.clml.2017.07.146
 - Extramedullary Multiple Myeloma: Clinical Features and Prognosis in Argentina10.1016/j.clml.2017.07.144
 - Semaphorin 4D correlates with increased bone resorption, hypercalcemia, and disease stage in newly diagnosed patients with multiple myelomaPubmed:29748532
 
